BOLTON SECURITIES CORPORATION’s Bionano Genomics BNGO Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$11	Buy	+4	New	+$26	﹤0.01%	1860

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Coldstream Capital Management Bellevue, Washington $8.21B AUM 20.06% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's BNGO Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Bionano Genomics (BNGO) in Q1 2025: 4 shares worth $11. The stake represents ﹤0.01% of the portfolio and ranks #1860 among its holdings.

31 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

BOLTON SECURITIES CORPORATION held 4 shares of Bionano Genomics worth $11 as of Q1 2025.
Bionano Genomics was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Bionano Genomics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #1860 holding.
31 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.